TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.230

+0.9%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 9wald9 who wrote (308)	8/10/2000 10:25:08 AM
From: Mike McFarland	of 557

IMNX gave Tgen license to TNF receptor gene, so that would be AAV-TNFR. --Deliver localized Enbrel gene-therapy to joints (apparently Enbrel is based on that Tumor Necrosis Factor). But don't go by me, let us run AAV TNF Immunex through the googleizer... AAV delivery of gene encoding ENBREL® shows promise in reducing inflammation in preclinical studies - noonanrusso.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next